Zoetis Debt to Equity Ratio 2011-2018 | ZTS

Current and historical debt to equity ratio values for Zoetis (ZTS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Zoetis debt/equity for the three months ending September 30, 2018 was 3.04.
Zoetis Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $6.44B $2.12B 3.04
2018-06-30 $4.96B $1.98B 2.50
2018-03-31 $4.95B $1.98B 2.51
2017-12-31 $4.95B $1.79B 2.77
2017-09-30 $4.95B $2.02B 2.45
2017-06-30 $3.72B $1.75B 2.13
2017-03-31 $3.72B $1.64B 2.27
2016-12-31 $4.47B $1.50B 2.98
2016-09-30 $4.47B $1.60B 2.80
2016-06-30 $4.47B $1.37B 3.26
2016-03-31 $4.46B $1.19B 3.76
2015-12-31 $4.46B $1.09B 4.09
2015-09-30 $3.23B $1.25B 2.57
2015-06-30 $3.24B $1.20B 2.70
2015-03-31 $3.24B $1.31B 2.49
2014-12-31 $3.62B $1.34B 2.71
2014-09-30 $3.64B $1.39B 2.62
2014-06-30 $3.64B $1.28B 2.84
2014-03-31 $3.64B $1.10B 3.31
2013-12-31 $3.64B $0.96B 3.79
2013-09-30 $3.64B $0.87B 4.21
2013-06-30 $3.64B $0.82B 4.42
2013-03-31 $3.64B $0.72B 5.03
2012-12-31 $0.51B $4.04B 0.13
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.58B $3.74B 0.15
2010-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $45.369B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $55.305B 11.85
Grifols (GRFS) Spain $14.134B 17.25
Tilray (TLRY) United States $10.566B 0.00
Neurocrine Biosciences (NBIX) United States $9.340B 2060.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.960B 12.86
Ionis Pharmaceuticals (IONS) United States $6.913B 0.00
Nektar Therapeutics (NKTR) United States $6.402B 9.18
Impax Laboratories (AMRX) United States $5.957B 31.68
Sage Therapeutics (SAGE) United States $5.694B 0.00
Catalent (CTLT) United States $5.515B 23.13
Loxo Oncology (LOXO) United States $4.943B 0.00
United Therapeutics (UTHR) United States $4.873B 7.97
Taro Pharmaceutical Industries (TARO) Israel $4.039B 14.96
FibroGen (FGEN) United States $3.347B 0.00
Endo (ENDP) Ireland $2.957B 4.53
USANA Health Sciences (USNA) United States $2.872B 24.44
Madrigal Pharmaceuticals (MDGL) United States $2.871B 0.00
Heron Therapeutics (HRTX) United States $2.149B 0.00
Xencor (XNCR) United States $2.071B 0.00
Aerie Pharmaceuticals (AERI) United States $2.030B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.987B 268.56
Endocyte (ECYT) United States $1.933B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.726B 0.00
PTC Therapeutics (PTCT) United States $1.632B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.487B 18.18
TESARO (TSRO) United States $1.487B 0.00
Zogenix (ZGNX) United States $1.465B 0.00
Corcept Therapeutics (CORT) United States $1.463B 21.48
Theravance Biopharma (TBPH) Cayman Islands $1.419B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.376B 0.00
Portola Pharmaceuticals (PTLA) United States $1.356B 0.00
Esperion Therapeutics (ESPR) United States $1.348B 0.00
Tricida (TCDA) United States $1.193B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.129B 0.00
TherapeuticsMD (TXMD) United States $1.120B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.784B 0.00
Radius Health (RDUS) United States $0.684B 0.00
Karyopharm Therapeutics (KPTI) United States $0.651B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.635B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
GlycoMimetics (GLYC) United States $0.528B 0.00
Collegium Pharmaceutical (COLL) United States $0.527B 0.00
ChemoCentryx (CCXI) United States $0.473B 37.44
Dova Pharmaceuticals (DOVA) United States $0.467B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.455B 0.00
Odonate Therapeutics (ODT) United States $0.451B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.450B 0.00
Xeris Pharmaceuticals (XERS) United States $0.448B 0.00
Akebia Therapeutics (AKBA) United States $0.441B 0.00
Dermira (DERM) United States $0.441B 0.00
ArQule (ARQL) United States $0.434B 0.00
OptiNose (OPTN) United States $0.427B 0.00
Aquestive Therapeutics (AQST) United States $0.415B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.406B 23.90
Siga Technologies (SIGA) United States $0.396B 0.00
Forty Seven (FTSV) United States $0.395B 0.00
Zafgen (ZFGN) United States $0.387B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.377B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.360B 0.00
Mast Therapeutics (SVRA) United States $0.346B 0.00
Depomed (ASRT) United States $0.344B 12.81
Minerva Neurosciences (NERV) United States $0.328B 0.00
KalVista Pharmaceuticals (KALV) United States $0.318B 0.00
Tapimmune (MRKR) United States $0.315B 0.00
Aratana Therapeutics (PETX) United States $0.309B 0.00
Aclaris Therapeutics (ACRS) United States $0.305B 0.00
Concert Pharmaceuticals (CNCE) United States $0.295B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.285B 0.00
Majesco Entertainment (PTE) United States $0.281B 0.00
CASI Pharmaceuticals (CASI) United States $0.279B 0.00
Translate Bio (TBIO) United States $0.270B 0.00
IMV INC (IMV) Canada $0.243B 0.00
Affimed (AFMD) Germany $0.240B 0.00
ElectroCore (ECOR) United States $0.237B 0.00
Opexa Therapeutics (ACER) United States $0.235B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.231B 0.00
MEI Pharma (MEIP) United States $0.219B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
Lannett Co Inc (LCI) United States $0.215B 1.88
Aldeyra Therapeutics (ALDX) United States $0.215B 0.00
Tyme Technologies (TYME) United States $0.212B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.201B 0.00
Galectin Therapeutics (GALT) United States $0.198B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.194B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.193B 0.00
Calithera Biosciences (CALA) United States $0.192B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Neon Therapeutics (NTGN) United States $0.185B 0.00
Ardelyx (ARDX) United States $0.183B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 0.00
ContraFect (CFRX) United States $0.168B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.165B 0.00
Molecular Templates (MTEM) United States $0.162B 0.00
MediWound (MDWD) Israel $0.154B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.152B 0.00
Recro Pharma (REPH) United States $0.150B 0.00
DURECT (DRRX) United States $0.148B 0.00
Melinta Therapeutics (MLNT) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Adherex Technologies (FENC) United States $0.135B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.128B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.124B 0.00
ProNAi Therapeutics (SRRA) Canada $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.110B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.109B 0.00
Rafael Holdings (RFL) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.101B 0.00
CTI BioPharma (CTIC) United States $0.097B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.095B 0.00
Achaogen (AKAO) United States $0.092B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.090B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Iterum Therapeutics (ITRM) Ireland $0.080B 0.00
Otonomy (OTIC) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.075B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Natural Alternatives (NAII) United States $0.070B 7.87
Immune Design (IMDZ) United States $0.066B 0.00
Forward Pharma (FWP) Denmark $0.066B 0.00
Novan (NOVN) United States $0.065B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 39.48
Actinium Pharmaceuticals (ATNM) United States $0.063B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Capnia (SLNO) United States $0.046B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
Trillium Therapeutics (TRIL) Canada $0.043B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
KemPharm (KMPH) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.88
Lipocine (LPCN) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.026B 0.00
IsoRay (ISR) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Biomerica (BMRA) United States $0.025B 0.00
NanoViricides (NNVC) United States $0.024B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 7.05
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Aradigm (ARDM) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 1.65
Eyegate Pharmaceuticals (EYEG) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Skyline Medical (AIPT) United States $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00